Close
Back to BMRN Stock Lookup
Pages: 1 2 »» Last Page

BioMarin Pharma (BMRN) – Major News

Apr 24, 2024 04:06 PM BioMarin Pharma (BMRN) Tops Q1 EPS by 39c ; Offers Guidance
Feb 22, 2024 04:05 PM BioMarin Pharma (BMRN) Tops Q4 EPS by 29c ; Offers Guidance
Nov 7, 2023 08:58 AM Activist Investor Elliott Takes Stake In Biomarin Pharmaceutical (BMRN), In Talks With Company About Its Future - Reuters
Nov 1, 2023 04:16 PM BioMarin Pharma (BMRN) Tops Q3 EPS by 23c; offers guidance
Jul 31, 2023 04:05 PM BioMarin Pharma (BMRN) Tops Q2 EPS by 31c, Offers Guidance
Apr 26, 2023 04:07 PM BioMarin Pharma (BMRN) Tops Q1 EPS by 39c
Feb 27, 2023 04:05 PM BioMarin Pharma (BMRN) Tops Q4 EPS
Oct 26, 2022 04:04 PM BioMarin Pharma (BMRN) Misses Q3 EPS by 2c
Aug 3, 2022 04:05 PM BioMarin Pharma (BMRN) Tops Q2 EPS by 12c, Offers Guidance
Apr 27, 2022 04:16 PM BioMarin Pharma (BMRN) Tops Q1 EPS by 46c
Feb 23, 2022 04:07 PM BioMarin Pharma (BMRN) Reports In-Line Q4 EPS
Oct 27, 2021 04:10 PM BioMarin Pharma (BMRN) Tops Q3 EPS by 4c
Jul 28, 2021 04:06 PM BioMarin Pharma (BMRN) Tops Q2 EPS by 18c
Apr 29, 2021 04:13 PM BioMarin Pharma (BMRN) Tops Q1 EPS by 19c, Offers FY Guidance
Feb 25, 2021 04:19 PM BioMarin Pharma (BMRN) Tops Q4 EPS by 31c
Nov 5, 2020 04:21 PM BioMarin Pharma (BMRN) Tops Q3 EPS, Lowers FY Revenue Guidance
Aug 4, 2020 04:16 PM BioMarin Pharma (BMRN) Misses Q2 EPS by 5c, Revenue Beats
Apr 29, 2020 04:03 PM BioMarin Pharma (BMRN) Tops Q1 EPS by 39c, Revs Beat; Trims FY Rev Outlook
Feb 26, 2020 04:08 PM BioMarin Pharma (BMRN) Tops Q4 EPS by 17c, Offers FY Guidance
Oct 23, 2019 04:16 PM BioMarin Pharma (BMRN) Tops Q3 Revenue
Aug 1, 2019 04:59 PM BioMarin Pharma (BMRN) Q2 Revenues Miss; Reaffirms FY Revs
Apr 25, 2019 04:11 PM BioMarin Pharma (BMRN) Misses Q1 EPS by 14c
Feb 21, 2019 04:25 PM BioMarin Pharma (BMRN) Posts Q4 Loss of $0.03/Share
Oct 25, 2018 04:10 PM BioMarin Pharma (BMRN) Tops Q3 EPS by 15c, Offers Guidance
Aug 2, 2018 04:22 PM BioMarin Pharma (BMRN) Tops Q2 EPS by 8c, Affirms FY Revenue Guidance, Lowers R&D Expense Guidance
Apr 25, 2018 04:06 PM BioMarin Pharma (BMRN) Misses Q1 EPS by 8c
Feb 22, 2018 04:16 PM BioMarin Pharma (BMRN) Misses Q4 EPS by 7c
Oct 26, 2017 04:13 PM BioMarin Pharma (BMRN) Tops Q3 EPS by 5c
Aug 2, 2017 04:27 PM BioMarin Pharma (BMRN) Reports In-Line Q2 EPS
May 4, 2017 04:06 PM BioMarin Pharma (BMRN) Tops Q1 EPS by 20c
Feb 23, 2017 04:04 PM BioMarin Pharma (BMRN) Posts Q4 Loss of $0.53
Oct 27, 2016 04:10 PM BioMarin Pharma (BMRN) Tops Q3 EPS by 13c, Revenue Misses
Aug 4, 2016 04:08 PM BioMarin Pharma's (BMRN) Q2 Revenue Tops Views
Apr 28, 2016 04:24 PM BioMarin Pharma (BMRN) Tops Q1 EPS by 32c, Offers Guidance
Feb 25, 2016 04:04 PM BioMarin Pharma (BMRN) Misses Q4 EPS Views
Oct 29, 2015 04:06 PM BioMarin Pharma (BMRN) Tops Q3 EPS by 5c; Raises Outlook
Aug 3, 2015 04:04 PM BioMarin Pharma (BMRN) Tops Q2 EPS by 2c, FY Guidance Unchanged
Feb 25, 2015 04:04 PM BioMarin Pharma (BMRN) Tops Q4 EPS by 12c
Nov 24, 2014 06:01 AM BioMarin Pharma (BMRN) to Acquire Prosensa (RNA) for $17.75/Share
Oct 23, 2014 04:30 PM BioMarin Pharma (BMRN) Tops Q3 EPS by 6c
Aug 26, 2014 04:28 PM BioMarin Pharma (BMRN) Lowers FY14 Revenue Forecast
Jul 30, 2014 04:56 PM BioMarin (BMRN) Tops Q2 EPS by 18c, Sells riority Review Voucher for $67.5 Million
Feb 26, 2014 04:20 PM BioMarin Pharmaceuticals, Inc. (BMRN) Reports Q4 Loss of 11c/sh
Nov 19, 2013 04:08 PM BioMarin's (BMRN) Vimizim Wins Backing of FDA Panel
Oct 24, 2013 05:05 PM BioMarin Pharma (BMRN) Posts Q3 GAAP Loss of 38c/Share
Sep 19, 2013 07:23 AM BioMarin Pharma (BMRN) Surges as Roche May Make Bid (ALXN)
Jul 25, 2013 04:23 PM BioMarin Pharmaceuticals, Inc. (BMRN) Tops Q2 EPS by 13c
Apr 25, 2013 04:43 PM BioMarin Pharmaceuticals, Inc. (BMRN) Misses Q1 EPS by 2c
Feb 21, 2013 04:39 PM BioMarin Pharmaceuticals, Inc. (BMRN) Posts Q4 GAAP Loss of 43c/Share; Guides FY13
Oct 25, 2012 04:08 PM BioMarin Pharmaceuticals, Inc. (BMRN) Tops Q3 EPS by 16c
Pages: 1 2 »» Last Page

Back to BMRN Stock Lookup